In today's second-round match-up of The Motley Fool's Better-Buy Tournament, Pfizer squares off against CONSOL Energy in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each other as they make the case for their stocks, with the winner determined by you, the readers.
In response to losing cash cow Lipitor, Pfizer (NYSE:PFE) reimagined itself as a focused drug-development company, selling off its nutrition business and spinning out its animal health division. Pfizer has five drugs with more than $2 billion in 2013 sales each, and Pfizer management is focused on shareholder value -- increasing the dividend while decreasing share count via buybacks. Pfizer's 3.2% dividend has a low payout ratio of only 30%, and the company is flush with cash, making increases likely in the future. Finally, drugs like Xeljanz and Prevnar have a strong growth trajectory, while developmental assets like palbociclib in breast cancer may be the next great Pfizer blockbuster, according to Motley Fool analyst David Williamson.
Motley Fool energy analyst Taylor Muckerman thinks CONSOL Energy (NYSE:CNX) should move to the next round because of its accelerating shift into natural gas. While it's the oldest coal producer in the nation, natural gas is CONSOL's future. To avoid being blindsided, though, CONSOL wisely chose to hold on to its lower-cost thermal coal mines and its solely owned export terminal as a nice hedge while the market shakes itself out. Other coal companies are probably jealous of this flexibility.
Watch these analysts square off in the following video, and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket.
This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
Cast your vote in the poll below the video!
David Williamson owns shares of Pfizer. Taylor Muckerman owns shares of CONSOL Energy. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.